An immunological signature to predict outcome in patients with triple-negative breast cancer with residual disease after neoadjuvant chemotherapy
- Resource Type
- Article
- Source
- In
ESMO Open August 2022 7(4) - Subject
Breast Cancer - Language
- ISSN
- 2059-7029